From NASDAQ:

Masimo MSA, a medical device company, has seen a significant downward pressure on its earnings estimates over the last two months, downgrading the stock to a Zacks Rank #5 (Strong Sell), indicating near-term weakness for the stock price. Known for its innovative Signal Extraction Technology (SET), Masimo develops and manufactures a range of vital sign monitoring devices. These technologies are widely used in healthcare settings to enhance patient safety by providing real-time and accurate data. Despite being a strong performer, MASI stock is facing numerous headwinds, leaving it vulnerable to a sell-off in the near future. Falling earnings estimates and near-flat sales growth over the next year have added to the stock’s risk, along with industry competition and product reimbursement uncertainty. Current quarterly earnings estimates have declined by -40% in just the last two months, with lower estimates expected for the near future. Even with these bearish catalysts, MASI has a relatively high earnings multiple. The current outlook for Masimo is both not promising, and only worsened by its rich valuation. Zacks investment research is naming awareness-worthy upcoming stocks for 2024. Sharaz Mian, the Director of Research is doling out the top 10 stock picks for 2024, potential investors could gain large profits. From 2012 until November 2023, the Zackst Top 10 Stocks gained +974.1% while the S&P 500 gained +340.1%. The best requirements for the best stocks to buy and hold in 2024 are being followed by Sheraz’s picks. Don’t miss out on these potential profitable stocks released on January 2.
Living up to the hype of delivering excellent performace, Masimo Technologies is keeping its eyes on the future. Patient monitoring is more important than ever, there is still a potentially promising future for the company. Unfortunately, until these near-term risk can current, investors should avoid Masimo stock, and look for opportunities elsewhere in the market. If you are interested in financial knowledge, would like to get the latest recommendations from Zacks Investment Research, go to zacks.com for more information. Please keep in mind that views and opinions of the author may not necessarily reflect those of Nasdaq, Inc.



Read more: Bear of the Day: Masimo (MASI)